Critical congenital heart disease screening by pulse oximetry in a neonatal intensive care unit. by Manja, V et al.
UC Davis
UC Davis Previously Published Works
Title
Critical congenital heart disease screening by pulse oximetry in a neonatal intensive care 
unit.
Permalink
https://escholarship.org/uc/item/2x34j8g0
Journal
Journal of perinatology : official journal of the California Perinatal Association, 35(1)
ISSN
0743-8346
Authors
Manja, V
Mathew, B
Carrion, V
et al.
Publication Date
2015
DOI
10.1038/jp.2014.135
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Critical Congenital Heart Disease Screening by Pulse Oximetry 
in a Neonatal Intensive Care Unit
Veena Manja, MBBS1,2, Bobby Mathew, MRCP3, Vivien Carrion, MD3, and Satyan 
Lakshminrusimha, MD3
1Division of Cardiology, State University of New York at Buffalo, Buffalo, New York
2Clinical Epidemiology and Biostatistics (Health-Research Methodology), McMasters University, 
Hamilton, Ontario, Canada
3Division of Neonatal-Perinatal Medicine, State University of New York at Buffalo, Buffalo, New 
York
Abstract
Critical congenital heart disease (CCHD) screening is effective in asymptomatic late preterm and 
term newborn infants with a low false positive rate (0.035%).
Objective—(1) To compare 2817 NICU discharges before and after implementation of CCHD 
screening; and (2) to evaluate CCHD screening at < 35 weeks gestation.
Methods—collection of results of CCHD screening including preductal and postductal SpO2 
values.
Results—During the pre-CCHD screen period, 1247 infants were discharged from the NICU and 
one case of CCHD was missed. After 3/1/12, 1508 CCHD screens were performed among 1570 
discharges and no CCHDs were missed. The preductal and postductal SpO2 values were 
98.8±1.4% and 99±1.3% respectively in preterm and 98.9±1.3% and 98.9±1.4% in term infants. 
Ten infants had false positive screens (10/1508=0.66%).
Conclusions—Performing universal screening in the NICU is feasible but is associated with a 
higher false positive rate compared to asymptomatic newborn infants.
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Introduction
Critical congenital heart disease (CCHD) is generally defined as congenital heart defect that 
requires surgery or catheter intervention within the first year of life or may cause significant 
morbidity and mortality in the first weeks of life1. Universal newborn pulse oximetry 
screening to detect CCHD was added to the recommended uniform screening panel (RUSP) 
by the Health and Human Services Secretary in 2011. CCHD screening through pulse 
oximetry (SpO2) is being implemented by many states and is shown to be cost-effective for 
asymptomatic newborn infants2. The false positive rate among asymptomatic newborn 
infants is low (0.035%)3, 4.
Approximately 10–12 % of all newborn infants are admitted to neonatal intensive care units 
(NICU). Many NICUs including ours routinely monitor SpO2 for all admissions. Limited 
data are available regarding CCHD screening in the NICU. Iyengar et al reported 250 
patients discharged from the NICU with CCHD screening at Northwestern University but 
did not report any positive screens 5. A recent commentary suggested three options for 
screening in the NICU: (i) consider that all NICU patients, by default, already undergo 
screening and not perform additional screening by pre-post ductal oxygen saturation 
difference; (ii) perform screening similar to that in normal newborn nursery in infants 35 
weeks and higher gestation or (iii) screen all infants admitted to the NICU 6. Many state 
governments recommend universal screening and do not differentiate between infants cared 
in the NICU vs. those admitted to newborn nursery.
Prior to initiation of CCHD screening, infants in our NICU did not undergo simultaneous 
preductal and postductal SpO2 monitoring unless there was suspicion of persistent 
pulmonary hypertension of the newborn (PPHN) or congenital heart disease (CHD). Our 
objective is to describe our experience with CCHD implementation in the NICU and to 
evaluate and report compliance with this procedure/process. We aim to report the frequency 
of CCHD diagnoses among NICU discharges. We evaluated readmissions with a primary 
diagnosis of CCHD to the Emergency Department or Pediatric Intensive Care following 
discharge from the NICU before and after implementation of CCHD screening. We also 
evaluated the results of CCHD screening and false positive rate among NICU discharges 
born at < 35 weeks and ≥35 weeks postmenstrual age (PMA).
Methods
The NICU at Women and Children’s Hospital of Buffalo serves as the regional perinatal 
center for Western New York. There were 61,869 births in Western New York per year 
between 1/1/2010 and 12/31/2013 (average 15,467 per year). Of these 6,944 infants were 
admitted over the four year period to any level 2/3 neonatal intensive care (11.2%) and had 
SpO2 monitoring during their stay in the NICU (average 1,736 per year). Of these, 3,152 
patients (average 788 patients per year) were admitted to the NICU at the Women and 
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Children’s Hospital of Buffalo. Only discharges from this NICU were evaluated in this 
study. The unit policy during this period was to maintain SpO2 between 91 and 95% in both 
preterm and term infants requiring supplemental oxygen.
Routine CCHD screening was implemented for all NICU discharges in early 2012. We 
conducted screening using Masimo Rad 7 pulse oximeters (Masimo Corporation, Irvine CA) 
and disposable probes. All patients in our NICU are continuously monitored with a pulse 
oximeter throughout their stay. The same probe was used to sequentially determine the right 
upper limb and a lower limb SpO2. Each screening attempt was conducted over a three 
minute period with the infant in the supine position. The pulse oximetry measure was 
considered complete once the wave form on the plethysmograph was stable 7. Infants 
discharged in 2010 and 2011 (pre-CCHD screen) were compared to NICU discharges from 
March 2012 to March 2014 (post-CCHD screen). All discharges were screened according to 
AAP guidelines with the following exceptions7. The screen was performed 24–48 hours 
prior to discharge from the NICU and at least 24 hours after weaning to room air (if the 
infant required supplemental oxygen). An echocardiogram was performed if the infant met 
the following criteria: (i) failed CCHD screen on room air (and if a prior echocardiogram 
was not performed during the NICU stay for other indications). Failed CCHD screen was 
defined as an SpO2 <90% in any extremity, a persistent SpO2 of 90–94% in both preductal 
and postductal sites on three attempts or a persistent preductal to postductal SpO2 difference 
> 3% 7, 8, (ii) unexplained need for oxygen (unable to maintain SpO2 ≥ 90% in room air), or 
(iii) inability to wean oxygen prior to discharge. A revised algorithm currently in use in our 
NICU was recently published 9. In order to detect false negatives, encounters and referrals to 
pediatric cardiology office, Emergency Department (ED), Pediatric Intensive Care Unit 
(PICU) and coroner’s office were evaluated.
Statistical analysis
The demographic features, incidence of echocardiographic evaluation in the pre- and post-
CCHD screening epochs and among preterm and term infants were analyzed by unpaired ‘t’ 
test or Chi-square test as appropriate. Significance was accepted at p < 0.05.
Results
Comparison between pre-screen and post-CCHD screen periods
During the pre-CCHD screen period, 1533 infants were admitted to the NICU at Women 
and Children’s Hospital of Buffalo and 1247 of them were directly discharged home (table 
1). Excluding prenatally suspected CCHD, twelve infants were diagnosed with CCHD based 
on clinical presentation during this period. 465 infants (37.3% of discharges) underwent 
echocardiography for clinical indications during this period. Sixty eight infants (5.5% of 
discharges) were sent home with oxygen supplementation. Five of these infants had 
moderate bronchopulmonary dysplasia (BPD) and did not have an echocardiogram prior to 
discharge. One infant with interrupted aortic arch and anomalous left subclavian artery was 
not diagnosed and discharged from the NICU in spite of continuous SpO2 and blood 
pressure monitoring 10. The precise site of pulse oximetry probe placement (pre- or 
postductal) could not be ascertained from our medical records. This infant was noted to have 
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absent femoral pulses at one week of age at the pediatrician’s office, was referred to 
cardiology for an echocardiogram which led to the diagnosis. The echocardiogram 
demonstrated complete interruption of the arch beyond the right subclavian artery. The left 
subclavian artery and descending aorta were supplied exclusively by the ductus arteriosus.
In early 2012, CCHD screening was reviewed with community pediatricians, hospital 
faculty, residents/ fellows, nurse practitioners/ physician assistants and nurses. A 
PowerPoint presentation with a flow chart and a color coded saturation chart 10 were utilized 
in the NICU.
Between March 2012 and March 2014, 1508 CCHD screens were performed among 1570 
discharges (figure 1). During the first month of implementation, nursing compliance with 
CCHD screen was 68%, improved to 92% by the 6th month and was 100% in 2013–14. 
Excluding prenatally diagnosed CCHD, 16 infants were diagnosed with CCHD based on 
abnormal physical examination and transferred to cardiac surgical service. 505 (32.2% of 
discharges) underwent echocardiogram for medical indications prior to discharge. Sixty four 
infants were discharged home with supplemental oxygen. Five of these infants did not have 
an echocardiogram for medical indications. These infants underwent echocardiogram to 
determine the etiology of oxygen need as per the modified CCHD algorithm. Four of these 
infants had a normal echocardiogram (1 – patent ductus arteriosus, PDA/ patent foramen 
ovale, PFO; 3 – PFO). One infant had supracardiac total anomalous pulmonary venous 
return (TAPVR). The preductal and postductal SpO2 were 88 and 91% respectively prior to 
oxygen supplementation in this infant.
Results of pulse oximetry screen
The median preductal and postductal SpO2 values were 99% (range − 90 to 100%) and 
100% (range 92 to 100%) respectively. No infant had a SpO2 value < 90% (by unit policy, 
these 64 infants were on supplemental oxygen). Eighteen infants in room air did not meet 
pass-criteria (18/1508= 1.2%) on first attempt of pulse oximetry screening (figure 1). One 
infant had both preductal and postductal SpO2 between 90 and < 95% and did not change 
with repeated screening attempts. Four infants had preductal SpO2 > postductal value by > 
3%. Postductal SpO2 exceeded preductal SpO2 by > 3% in 13 infants. After repeat preductal 
and postductal SpO2 measurements, 10 infants (0.66%, figure 1) failed the screen (1-<95%, 
3-preductal > postductal SpO2 by >3% and 6- postductal > preductal SpO2 by > 3%). 
Echocardiogram showed mild pulmonic stenosis, AV malformation and patent foramen 
ovale or patent ductus arteriosus (PFO/PDA) or PPHN in these infants. Postductal SpO2 
exceeded preductal SpO2 by > 3% in 6 infants. Three infants had normal anatomy (PFO ± 
PDA), and one had tricuspid regurgitation. Two infants whose postductal saturations were 
100% and preductal were 96% on final repeat screen were labeled as passed and discharged 
home without an echocardiogram. None of the infants discharged from the NICU were 
diagnosed to have CCHD on follow-up visits to their pediatrician/ family practitioner, ED/ 
PICU or readmission during the period of CCHD screen. Of note, one infant discharged 
from a level 1 nursery after a normal CCHD screen was readmitted and transferred to us 
with CCHD during the same period (ventricular septal defect with transverse arch 
hypoplasia and coarctation of the aorta). Two infants with failed CCHD screens in level 1 
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nursery were transferred to the NICU during this period (one with tetralogy of Fallot and 
another with TAPVR).
Differences between preductal and postductal SpO2
Fifty two percent of infants had the same preductal and postductal SpO2. Preductal 
saturations were higher than postductal in 18% of infants and less than postductal in 30% of 
infants. The frequency distribution of the difference between preductal and postductal 
oxygen saturations is shown in figure 2.
Differences between preterm and term neonates in the NICU
There was no significant difference in SpO2values in preterm (<35 weeks PMA) and term 
(≥35 weeks PMA) infants. The cut-off of 35 weeks was chosen as all infants < 35 weeks 
PMA are initially admitted to the NICU in our institution. More preterm infants had at least 
one prior echocardiogram for clinical indications (43 vs. 27%, p < 0.01 by Chi2 test). The 
false positive rate was not significantly different between preterm and term infants (table 2).
Discussion
Many states including the state of New York have mandated universal pulse oximetry 
screening of all newborn infants. March of Dimes estimates that about 10–15% of U.S. 
babies spend time in a NICU each year. These infants undergo multiple physical 
examinations and are continuously monitored by pulse oximetry. There is limited literature 
on the use of pulse oximetry screening in the NICU 5, 6, 10. To our knowledge this study 
represents the largest series of universal CCHD screening among the NICU population.
Universal screening for CCHD was implemented initially in our NICU as a quality 
improvement measure following the discharge of a term infant with interrupted aortic 
arch10. It is not clear if we would have detected this patient by CCHD screening. Detection 
rates for coarctation of aorta are < 60% by CCHD screening 3. Although precise detection 
rates for interrupted aortic arch by pulse oximeter screening are not known and this 
diagnosis has been missed by CCHD screen8, we speculate that the saturations in the left 
upper limb and lower limbs (ductal-dependent systemic circulation) in this infant would be < 
90%. Simultaneous preductal and postductal SpO2 measurement at CCHD screen may be 
beneficial in the NICU. Moreover, infants already have a disposable pulse oximeter probe 
reducing the cost of CCHD screen in the NICU.
Approximately a third of the discharges from our NICU had a prior echocardiogram for 
medical indications. In the current study, these infants were also screened; we have recently 
revised our protocol and infants who have had prior echocardiograms in the NICU are not 
screened. Instead the date of the echocardiogram and the main findings are recorded in the 
CCHD screen folder of the electronic medical record significantly reducing the number of 
screens required in the NICU.
During the two-year period of screening, only one patient with CCHD (TAPVR) was 
diagnosed using the screen algorithm. This term infant was symptomatic with an 
unexplained oxygen need and this echocardiogram would have been performed as part of his 
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medical evaluation irrespective of the CCHD screening protocol. Since TAPVR would have 
likely been diagnosed even without CCHD screening in place, the probability of a new 
CCHD diagnosis from a screening program in the NICU is not known with certainty. Pooled 
data from many NICUs are needed to evaluate the precise true positive rate of CCHD 
screening in the NICU and the costs involved per additional CCHD diagnosed. There were 
no cases of CCHD detected among NICU discharges in the Pediatrician/ family 
practitioner’s office, cardiology or Emergency Department/ PICU. The Women and 
Children’s Hospital of Buffalo is the only Pediatric Emergency Department / PICU and 
neonatal/ pediatric transport team in Western New York.
One notable difference when compared to non-NICU neonates in the current study is the 
high rate of false positive screens in the NICU population. Meta-analyses of large 
population-based studies of newborn pulse oximetry screening conducted after the first 24h 
after delivery among asymptomatic newborn infants, demonstrate a low false-positive rate 
of 0.035 4 to 0.05% 11. The false-positive rate in our study was significantly higher at 0.66% 
in a high-morbidity NICU population. As almost a third of patients undergo 
echocardiography in our NICU, this false positive rate results in a small additional need for 
echocardiograms. Similar high false positive rates are documented for high-risk population 
with endocrine/metabolic newborn screen (1.05% in term infants vs. 6.9% in preterm 
infants, 6% for low birth weight and 4.9% for infants with chronic illness) 12.
Two-thirds of these false-positive screens were secondary to a postductal SpO2 in the 99–
100% range and a preductal SpO2 of 95–96% (n=13 on first attempt and 6 after subsequent 
attempts). In infants with both pre- and postductal SpO2 ≥95%, if preductal to postductal 
difference of >3% was not a criterion for screen failure, the false positive rate in our NICU 
would be reduced to 0.07%, similar to the rate in asymptomatic newborn infants. It is 
interesting to note that among studies conducted > 24h of life, Riede et al evaluated foot 
oximetry only in 41,445 births and demonstrated a sensitivity of 77.8% and a false-positive 
rate of 0.1% 13. In contrast, de-Wahl Granelli et al conducted simultaneous preductal and 
postductal oximetry in 39,821 births with a sensitivity of 62% and a false-positive rate of 
0.17 %8.
Ten neonates had postductal SpO2 exceed preductal SpO2 by >3% on the first attempt 
suggestive reverse differential “cyanosis”. Two CCHD lesions are associated with reverse 
differential cyanosis. The first is transposition of great arteries (TGA) associated with 
PPHN14 or TGA with coarctation/interrupted aortic arch 15, 16. The SpO2 in these patients is 
often < 80%. The second condition reported in one case with reverse differential cyanosis is 
supradiaphragmatic TAPVR17. The preductal SpO2 was 80% and postductal SpO2 was 93% 
on 60% inspired oxygen in this patient. Patients with both preductal and postductal SpO2 
≥95% in room air are highly unlikely to suffer from TGA or TAPVR. Should infants with 
postductal SpO2 exceeding preductal SpO2 by >3% and with baseline preductal and 
postductal SpO2 of greater than 95% on room air be considered to have passed the screen 
(with no possibility of CCHD)?
Approximately half of the NICU patients had no difference between preductal and 
postductal SpO2 (figure 2), but postductal SpO2 was significantly higher than preductal 
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values in the NICU population (99 ± 1.3% vs. 98.8 ± 1.4%, p < 0.0001). Interestingly, a 
similar trend was observed in normal newborn infants 24h after birth 18.
In spite of presentations and color charts readily available in the NICU with the correct 
algorithm for the screen, two infants with failed screens (with postductal SpO2 of 100% and 
preductal SpO2 of 96%) were erroneously labeled as passed and were discharged without an 
echocardiogram. Intensive and repeated educational efforts and close collaboration between 
neonatal and cardiology services can mitigate such errors. There are several limitations to 
this study. We did not evaluate the optimal timing for CCHD screen in the NICU. We 
performed the screen 24–48h prior to discharge along with other screening tests such as car-
seat challenge and hearing screen. It is possible that screening may be conducted earlier (at 
24–48 h of age for neonates in room air and 24 h after weaning to room air in infants 
requiring supplemental oxygen / respiratory support). Secondly, not all NICUs monitor 
patients SpO2 continuously throughout the length of stay. Finally, the incidence of CCHD is 
low and the current single-center study is underpowered to make any definitive conclusions 
in this population.
We conclude that performing universal screening in the NICU is feasible but may not be 
effective as a stand-alone tool. A thorough history and physical examination will provide 
clues to the diagnosis of CCHD in many infants. Pulse oximetry screening may enhance the 
effectiveness of CCHD diagnosis by clinical examination. CCHD can potentially be missed 
by not performing a pre- and postductal SpO2 screen prior to discharge in the NICU. The 
false-positive rate for CCHD screen is higher in the NICU compared to asymptomatic 
newborns in a level 1 nursery and is mainly due to >3% difference in pre- and postductal 
SpO2. Data analyses from multiple units are needed to determine the precise false-positive 
and true-positive rate and effectiveness among neonates admitted to the NICU.
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Figure 1. 
Flowchart showing distribution of patients based on universal screen conducted in the NICU 
from March 2012 to March 2014. Abbreviations: CCHD – critical congenital heart disease, 
NICU – neonatal intensive care unit; PDA – patent ductus arteriosus; PFO – patent foramen 
ovale; PPHN – persistent pulmonary hypertension of the newborn; TAPVR – total 
anomalous pulmonary venous return.
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Figure 2. 
The frequency distribution (%) of the difference between preductal and postductal 
saturations in preterm (less than or equal to 34 weeks 6/7 days PMA) and term neonates 
(greater than or equal to 35 weeks 0/7 days PMA) and all infants.
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Table 1
Patient characteristics pertaining to CCHD at Women and Children’s Hospital of Buffalo NICU during period 
1 (Jan 2010 to Dec 2011 – no CCHD screening) and period 2 (March 2012 to March 2014 – CCHD screening)
No CCHD screening (Jan 
2010 – Dec 2011)
CCHD screening (Mar 2012 
to Mar 2014)
Total number of admissions 1533 1975
Number of direct discharges home (excluding transfers, transfer of service 
and deaths)
1247 1570
Number of CCHD diagnosed during the NICU course (excluding antenatal 
diagnosis)
12 16
Number of CCHD screens performed n/a 1508 (96.1% of discharges)
Infants with echocardiograms performed for clinical indications 465 (37.3% of discharges) 505 (31.8% of discharges)
Infants discharged home on oxygen (or unable to wean off oxygen prior to 
CCHD screen)
68 64
Infants unable to be weaned to room air prior to screen who have not had 
an echo for clinical indication
5 5
True positives N/A 1 – TAPVR (unexplained 
oxygen requirement)
Missed patients – readmissions and underwent intervention 1 – interrupted aortic arch 0
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Table 2
CCHD screen characteristics at < 35 weeks gestation and ≥35 weeks gestation at birth [data are shown as 
mean (SD)]
“Preterm” < 35 weeks “Term” ≥35 weeks
N 619 889
Gestational age weeks 31.1 (2.8)
Range – 22 to 34
38 (1.7)
Range – 35 to 41
Birth weight grams 1700 (598)
Range – 438 to 5081
3146 (679)
Range – 1318 to 6010
Race:
Caucasian 385 554
Black 168 205
Hispanic 39 44
Asian/other 27 86
Postmenstrual age at CCHD screening 
(weeks)
36.9 (2.5)
Median – 36.4
Range – 33.3 to 46.7
39.4 (2.2)
Median – 39.3
Range – 35.6 to 50
Preductal SpO2 98.8 (1.4)%
Median – 99%
Range – 92 to 100%
98.9 (1.3)%
Median – 99%
Range – 93 to 100%
Post ductal SpO2 99.1 (1.3)%
Median – 100%
Range – 94 100%
98.9 (1.4)%
Median – 99%
Range – 92 to 100%
Pre-post difference − 0.23 (1.2)% − 0.14 (1.3)%
Echocardiogram for clinical indications 264 (43%) 241 (27%)*
Echocardiogram as baby was being 
discharged on oxygen (and had not had an 
echocardiogram before for clinical 
indication)
2/57 patients not weaned off oxygen by 
discharge
3/7 patients not weaned off oxygen by discharge
False positive screen 3 (0.48%) 7 (0.78%)
True positive screen 0 1
*p < 0.01 by Chi2 test
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